Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Berben

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Pharmaceutical Sciences|August 23, 2017
Assessment of Passive Intestinal Permeability Using an Artificial Membrane Insert SystemPhilippe Berben, Joachim Brouwers, Patrick Augustijns
International Journal of Pharmaceutics|December 16, 2017
The artificial membrane insert system as predictive tool for formulation performance evaluationPhilippe Berben, Joachim Brouwers, Patrick Augustijns
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 24, 2017
The effect of 2-hydroxypropyl-β-cyclodextrin on the intestinal permeation through mucusJef Stappaerts, Philippe Berben, Irem Cevik, et al.
International Journal of Pharmaceutics|April 29, 2017
Gastrointestinal behavior of itraconazole in humans - Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solutionPhilippe Berben, Raf Mols, Joachim Brouwers, et al.
International Journal of Pharmaceutics|February 4, 2017
Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parametersManoela K Riekes, Aswin Dereymaker, Philippe Berben, et al.
Pharmaceutics|April 28, 2023
Characterization of Aspirated Duodenal Fluids from Parkinson's Disease PatientsTom de Waal, Joachim Brouwers, Philippe Berben, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 1, 2018
Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox<sup>®</sup>Philippe Berben, Jef Stappaerts, Matthias J A Vink, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 17, 2018
Drug permeability profiling using cell-free permeation tools: Overview and applicationsPhilippe Berben, Annette Bauer-Brandl, Martin Brandl, et al.
Molecular Pharmaceutics|November 13, 2023
Contribution of the Dynamic Intestinal Absorption Model (Diamod) to the Development of a Patient-Centric Drug FormulationFrédéric Moens, Adam Larsson, Anke De Blaiser, et al.
European Journal of Medicinal Chemistry|May 10, 2017
Synthesis and preclinical evaluation of [<sup>11</sup>C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)Muneer Ahamed, Bala Attili, Daisy van Veghel, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical Sciences|August 23, 2017
Assessment of Passive Intestinal Permeability Using an Artificial Membrane Insert SystemPhilippe Berben, Joachim Brouwers, Patrick Augustijns
International Journal of Pharmaceutics|December 16, 2017
The artificial membrane insert system as predictive tool for formulation performance evaluationPhilippe Berben, Joachim Brouwers, Patrick Augustijns
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 24, 2017
The effect of 2-hydroxypropyl-β-cyclodextrin on the intestinal permeation through mucusJef Stappaerts, Philippe Berben, Irem Cevik, et al.
International Journal of Pharmaceutics|April 29, 2017
Gastrointestinal behavior of itraconazole in humans - Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solutionPhilippe Berben, Raf Mols, Joachim Brouwers, et al.
International Journal of Pharmaceutics|February 4, 2017
Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parametersManoela K Riekes, Aswin Dereymaker, Philippe Berben, et al.
Pharmaceutics|April 28, 2023
Characterization of Aspirated Duodenal Fluids from Parkinson's Disease PatientsTom de Waal, Joachim Brouwers, Philippe Berben, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 1, 2018
Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox<sup>®</sup>Philippe Berben, Jef Stappaerts, Matthias J A Vink, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 17, 2018
Drug permeability profiling using cell-free permeation tools: Overview and applicationsPhilippe Berben, Annette Bauer-Brandl, Martin Brandl, et al.
Molecular Pharmaceutics|November 13, 2023
Contribution of the Dynamic Intestinal Absorption Model (Diamod) to the Development of a Patient-Centric Drug FormulationFrédéric Moens, Adam Larsson, Anke De Blaiser, et al.
European Journal of Medicinal Chemistry|May 10, 2017
Synthesis and preclinical evaluation of [<sup>11</sup>C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)Muneer Ahamed, Bala Attili, Daisy van Veghel, et al.
Pageof 2